Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (2) , 177-182
- https://doi.org/10.1023/a:1008318930947
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid LeukemiaBlood, 1997
- Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- Economic Analyses of Phase III Cooperative Cancer Group Clinical Trials: Are They Feasible?Cancer Investigation, 1997
- Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.Journal of Clinical Oncology, 1996
- Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)Blood, 1995
- A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.Journal of Clinical Oncology, 1994
- Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute LeukemiaNew England Journal of Medicine, 1990